Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2824 of 5804
-
New oral diabetes drug shows promise in early safety trial
Disease control CompletedThe main purpose of this study is to learn about the side effects of LY3502970 when given to Japanese participants with type 2 diabetes mellitus (T2DM). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. For…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Tailored surgery may help kids with sleep apnea who have small tonsils or down syndrome
Disease control CompletedThe purpose of this study is to prospectively compare the effectiveness of a novel personalized approach to the surgical treatment of obstructive sleep apnea (OSA) in children, drug induced sleep endoscopy (DISE) directed surgery versus the standard adenotonsillectomy (AT). This …
Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Experimental drug targets Hard-to-Treat lung cancer
Disease control TerminatedThis study is researching an experimental drug called REGN5093-M114 by itself and in combination with cemiplimab. The study is focused on advanced non-small cell lung cancer (NSCLC) that produces too much of a protein called mesenchymal epithelial transition factor (MET) on the c…
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New combo therapy for advanced breast cancer shows promise in early trial
Disease control CompletedThis is a multicenter, open-label, non-controlled, phase I study to investigate the tolerability and safety of ONO-4578 used in combination with standard-of-care letrozole and a CDK4/6 inhibitor (palbociclib or Abemaciclib) as first-line endocrine therapy in postmenopausal patien…
Phase: PHASE1 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Phone therapy may lift mood in epilepsy patients
Symptom relief Recruiting nowThis is a two-arm randomized controlled trial to compare telephone-based depression self-management (UPLIFT) to telephone-based support groups (BOOST). A sample of 120 English- and Spanish-speaking people with epilepsy (PWE) with elevated depressive symptoms will be enrolled. Bot…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Can a simple check at discharge prevent medication errors?
Disease control CompletedFrom a regulatory point of view, medication reconciliation is a necessary process to ensure safe medication management for patients. According to national studies and the international scientific literature, the information received by patients and health professionals at dischar…
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
C-Section pain pump put to the test: could it cut opioid need?
Symptom relief Recruiting nowThis study plans to learn more about postoperative pain management after cesarean deliveries (C-sections). As a part of standard of care, the Children's Hospital Colorado's Colorado Fetal Care Center (CFCC) follows the standard Enhanced Recovery After Cesarean (ERAC) guidelines t…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Kindness as medicine: can compassion training beat stress for students?
Symptom relief CompletedUniversity life is a challenging period. College students are exposed to a large number of stressors such as increased workload, multitasking, new responsibilities, changes in sleep and eating habits, social stressors, financial concerns and future employability, unlimited access…
Phase: NA • Sponsor: Hospital Miguel Servet • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New lifestyle program aims to help Prader-Willi patients keep weight off
Disease control CompletedPrader-Willi syndrome (PWS) is a rare and complex genetic disease characterized by hypothalamic-pituitary axis dysfunction combining eating disorders associated with hyperphagia and satiety deficiency, mild intellectual deficit and behavioral disorders. This disease requires cont…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Back surgery patients may need fewer opioids with simple steroid trick
Symptom relief Recruiting nowThis study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedu…
Phase: PHASE3 • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New hope for Tough-to-Treat hypertension in kidney patients?
Disease control TerminatedThis Phase 3, randomized, Double-blind, placebo-controlled, 2-arm, parallel-group, multicenter study with randomized withdrawal will evaluate the efficacy, safety, and durability of KBP-5074 in adult participants who have stage 3b/4 chronic kidney disease (CKD) (estimated glomeru…
Phase: PHASE3 • Sponsor: KBP Biosciences • Aim: Disease control
Last updated Jun 26, 2026 12:43 UTC
-
New drug SG301 tested in blood cancer patients who have run out of options
Disease control OngoingThis is a Phase 1a/1b Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SG301 in Patients with Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies
Phase: PHASE1 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Telehealth therapy aims to cut opioid use for back pain sufferers
Symptom relief OngoingThe goal of this study is to improve pain management and reduce opioid reliance for patients with chronic back pain in Utah Federally-Qualified Health Centers (FQHCs). The study compares the effectiveness of nonpharmacologic pain treatments using telehealth to overcome access bar…
Phase: PHASE3 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Double blood thinner strategy after vein stenting aims to prevent Re-Clotting
Disease control Recruiting nowTo evaluate the efficacy and safety of combination of anticoagulant and antiplatelet therapy on the patency of iliac vein at 12-month post stenting in patients with acute proximal DVT and ipsilateral iliac vein stenosis who received percutaneous mechanic thrombectomy and iliac ve…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Prostate drug tested on women for bladder relief after surgery
Symptom relief Recruiting nowThe objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.
Phase: PHASE2 • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Botulinum injection trial for arm spasticity halted early
Disease control TerminatedPhase 2/3, randomized, double-blind, placebo-controlled, single-treatment, multicenter trial assessing the efficacy and safety of MYOBLOC for the treatment of upper limb spasticity in adults followed by an open-label extension safety trial.
Phase: PHASE2, PHASE3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Lab-Grown tumors used to test supercharged immune cells against breast cancer
Knowledge-focused Recruiting nowCell-based immune therapy using modified macrophages is a promising therapeutic approach in breast cancer. The objective of this cohort study is to collect tumor samples to develop patients' derived organoids to test the antitumor activity of newly developed CAR-macrophages. Othe…
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Could a daily aspirin boost ovarian cancer treatment?
Disease control Recruiting nowThe purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking surgery, in women with diagnosed ovarian, fallopian tube, or peritoneal carcinoma
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug shows promise for anemia in diabetic kidney patients
Disease control CompletedThis study is a single-arm, open-label, multicenter and prospective study, which is conducted to evaluate the effect of Roxadustat on anemia in subjects with DKD (stage III-IV).
Phase: PHASE4 • Sponsor: Second Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
CO2 clue may help doctors treat shock patients better
Disease control CompletedThe management of a patient with shock is based on improving tissue oxygenation through hemodynamic optimization. Lactate is a marker of tissue hypoperfusion commonly used in the ICU. In principle, hyperlactatemia can be caused by either increased tissue production (tissue hypope…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC